Etanercept treatment in patients with rheumatoid arthritis on dialysis.
Nakamura
Tadashi
T
Section of Medicine and Rheumatology, Kumamoto Center For Arthritis and Rheumatology, 1-15-7 Kuhonji, Kumamoto, 862-0976, Japan. naktrkme@koh.marutakai.or.jp
Higashi
Syu-Ichi
S
Tomoda
Kunihiko
K
Tsukano
Michishi
M
Arizono
Kenzi
K
Nakamura
Takamichi
T
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000009:adverse effects*; D007674:Kidney Diseases / Q000150:complications* / Q000503:physiopathology* / Q000628:therapy; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept